FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - BOERSE MUENCHEN 11:57:25 24/05/2024 pm IST | ||
| 6.25 EUR | -3.85% |
|
| Current month | +49.88% | ||
| 1 month | +49.88% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24/24/24 | 6.25 | -3.85% |
| 23/24/23 | 6.5 | -6.20% |
| 22/24/22 | 6.93 | -1.56% |
| 21/24/21 | 7.04 | -1.12% |
| 20/24/20 | 7.12 | +3.04% |
Real-time BOERSE MUENCHEN
Last update May 24, 2024 at 11:57 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GK3H4T |
| ISIN | DE000GK3H4T2 |
| Date issued | 14/04/2022 |
| Strike | 247.5 $ |
| Maturity | Unlimited |
| Parity | 9.03 : 1 |
| Emission price | 10.07 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.02 € |
|---|---|
| Lowest since issue | 2.246 € |
| Spread | 0.05 € |
| Spread % | 0.80% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Certificates
- Certificat
